Jens Randel Nyengaard

Prof. Jens Randel Nyengaard

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2008 in The Anatomical Record
Verified
Journal Article
Closed access
PDF file
JKJuliane Knust
Juliane Knust
MOMatthias Ochs
Matthias Ochs
HGHans Jørgen G. Gundersen
Hans Jørgen G. Gundersen
JNJens Randel Nyengaard
Jens Randel Nyengaard

4 January 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LRLine Reinert
Line Reinert
ARAhmad S. Rashidi
Ahmad S. Rashidi
DTDiana N. Tran
Diana N. Tran
GKGeorgios Katzilieris-Petras
Georgios Katzilieris-Petras
AHAstrid K. Hvidt
Astrid K. Hvidt
SPSøren R. Paludan
Søren R. Paludan
Protection of the brain from viral infections involves the type I IFN (IFN-I) system, defects in which render humans susceptible to herpes simplex encephalitis (HSE). However, excessive cerebral IFN-I levels lead to pathologies, suggesting the need for tight regulation of responses. Based on data from mouse models, human HSE cases, and primary cell culture systems, we showed that microglia and other immune cells undergo apoptosis in the HSV-1–infected brain through a mechanism dependent on the cyclic GMP-AMP synthase/stimulator of interferon genes (cGAS/STING) pathway, but independent of IFN-I. HSV-1 infection of microglia induced cGAS-dependent apoptosis at high viral doses, whereas lower viral doses led to IFN-I responses. Importantly, inhibition of caspase activity prevented microglial cell death and augmented IFN-I responses. Accordingly, HSV-1–infected organotypic brain slices or mice treated with a caspase inhibitor exhibited lower viral load and an improved infection outcome. Collectively, we identify an activation-induced apoptosis program in brain immune cells that downmodulates local immune responses.

22 January 2021 in Pain
Verified
Journal Article
Open access
PRPuneet Rinwa
Puneet Rinwa
LCLaura Calvo-Enrique
Laura Calvo-Enrique
MZMing-Dong Zhang
Ming-Dong Zhang
JNJens Randel Nyengaard
Jens Randel Nyengaard
PKPáll Karlsson
Páll Karlsson
PEPatrik Ernfors
Patrik Ernfors
Recent findings indicate that nociceptive nerves are not “free”, but similar to touch and pressure sensitive nerves, terminate in an end-organ in mice. This sensory structure consists of the nociceptive nerves and specialized nociceptive Schwann cells forming a mesh-like organ in subepidermis with pain transduction initiated at both these cellular constituents. The intimate relation of nociceptive nerves with nociceptive Schwann cells in mice raises the question whether defects in nociceptive Schwann cells can by itself contribute to pain hyperalgesia, nerve retraction, and peripheral neuropathy. We therefore examined the existence of nociceptive Schwann cells in human skin and their possible contribution to neuropathy and pain hyperalgesia in mouse models. Similar to mouse, human skin contains SOX10+/S100B+/AQP1+ Schwann cells in the subepidermal border that have extensive processes, which are intimately associated with nociceptive nerves projecting into epidermis. The ablation of nociceptive Schwann cells in mice resulted in nerve retraction and mechanical, cold, and heat hyperalgesia. Conversely, ablating the nociceptive nerves led to a retraction of epidermal Schwann cell processes, changes in nociceptive Schwann cell soma morphology, heat analgesia, and mechanical hyperalgesia. Our results provide evidence for a nociceptive sensory end-organ in the human skin and using animal models highlight the interdependence of the nerve and the nociceptive Schwann cell. Finally, we show that demise of nociceptive Schwann cells is sufficient to cause neuropathic-like pain in the mouse.

27 August 2009 in The Anatomical Record
Verified
Journal Article
Open access
PDF file
YTYong Tang
Yong Tang
JNJens Randel Nyengaard
Jens Randel Nyengaard
JAJohnnie B. Andersen
Johnnie B. Andersen
UBUlrik Baandrup
Ulrik Baandrup
HGHans Jørgen G. Gundersen
Hans Jørgen G. Gundersen
This study describes and exemplifies generally applicable design‐based stereological methods for obtaining quantitative estimates of the numbers and sizes of capillaries, cardiomyocytes, and cardiomyocyte nuclei in immersion‐fixed human left ventricles (N = 6). The design‐based stereological methods are valid in all cardiac investigations onto quantifying changes in structure and function as seen under various conditions such as during development, aging, hypertrophy, and following ischemia/reperfusion. The applied principles of unbiased stereology were as follows: 1) uniform random sampling was taken at all levels, also in respect to orientations, for estimates of length and mean sizes. 2) All global structural quantities were estimated as total quantity = density × volume of the left ventricle. As an example, the left ventricle contains 1.5 × 109 capillaries with a total length of just below 200 km. 3) Stereological methods were used for estimating the volume density, surface area density, and length density of capillaries and cardiomyocytes. The numerical density of cardiomyocyte nuclei and capillaries was estimated, using the optical and physical disector, respectively. 4) In all local quantities, “size” was estimated either directly, using unbiased estimators to obtain the average individual size and size distribution parameters, or indirectly, using the relationship that: average size = total quantity/total number. In the six hearts constituting this study, we observed the anticipated correlation between left ventricular volume and global estimates such as total number of capillaries. There were no correlation between local quantities and total left ventricular volume (e.g., average star volume of individual cardiomyocytes). Anat Rec, 2009.

17 June 2025 in Cell
Verified
Journal Article
Open access
MWMarcel S. Woo
Marcel S. Woo
JBJohannes Brand
Johannes Brand
LBLukas C. Bal
Lukas C. Bal
MMManuela Moritz
Manuela Moritz
MWMark Walkenhorst
Mark Walkenhorst
MFManuel A. Friese
Manuel A. Friese
Inflammation, aberrant proteostasis, and energy depletion are hallmarks of neurodegenerative diseases such as multiple sclerosis (MS). However, the interplay between inflammation, proteasomal dysfunction in neurons, and its consequences for neuronal integrity remains unclear. Using transcriptional, proteomic, and functional analyses of proteasomal subunits in inflamed neurons, we found that interferon-γ-mediated induction of the immunoproteasome subunit, proteasome 20S beta 8 (PSMB8) impairs the proteasomal balance, resulting in reduced proteasome activity. This reduction causes the accumulation of phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a key metabolic regulator, leading to enhanced neuronal glycolysis, reduced pentose phosphate pathway activity, oxidative injury, and ferroptosis. Neuron-specific genetic and systemic pharmacological targeting of PSMB8 or PFKFB3 protected neurons in vitro and in a mouse model of MS. Our findings provide a unifying explanation for proteasomal dysfunction in MS and possibly other neurodegenerative diseases, linking inflammation to metabolic disruption, and presenting an opportunity for targeted neuroprotective therapies.

19 March 2012 in APMIS
Verified
Journal Article
Closed access
PDF file
SKSarah Line Brøgger Kristiansen
Sarah Line Brøgger Kristiansen
JNJens Randel Nyengaard
Jens Randel Nyengaard